Data / Form D filings / Couragene, Inc.
Couragene, Inc.: Form D filings
Couragene, Inc., a biotechnology company in Edison, NJ, filed 2 Form D notices with the SEC between 2022 and 2024. The latest, on May 22, 2024, reports $1 million sold of a $1 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 46 DALE DRIVE, Edison, NJ, 08820
- Phone
- (732) 713-8877
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2022
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1945169
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 22, 2024 | New notice | $1,000,000 | $1,000,000 | 1 | Apr 3, 2024 | sec.gov | |
| Sep 6, 2022 | New notice | $4,000,000 | $2,600,000 | $1,400,000 | 7 | Aug 24, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Mike Hanrahan | Director | |
| Guojuan Liao | Director, Executive Officer, Promoter | |
| Jiangbing Zhou | Director | |
| Jinlin Wang | Director |
Other biotechnology companies in New Jersey that filed recently
- Ensho Therapeutics, Inc. $7.3 million · Oct 15, 2026
- Xenon Ophthalmics Inc $3.3 million · Oct 6, 2026
- LISATA THERAPEUTICS, INC. $351.9 million · Oct 2, 2026
- Bullseye Biodevices, Inc. $1.3 million · Aug 10, 2026
- Hepion Pharmaceuticals, Inc. $3.1 million · Aug 5, 2026
Every Form D from the week of May 20, 2024 · All recent filings in New Jersey · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Couragene, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.